To establish a Nipa-deficient ALCL-like disease without “off-target” effects of Nipa deficiency, we used donor BMCs from LckCreTG/wtNipaflox/flox mice for MSNAIE infection, thus restricting NPM-ALK expression and Nipa deletion to the identical T cells. This evidence concerns the gene NPM1 and anaplastic large cell lymphoma.